Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT03225547

Terminated

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Breast Cancer | Triple Negative Breast Neoplasms
NCT04603820

Active, not recruiting

Registry Study of Pregnancy and Breast Cancer (EMBARCAM)

Breast Cancer and Pregnancy
NCT05253911

Completed

Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens. (TRACE)

HER2-positive Breast Cancer
NCT06495164

Active, not recruiting

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Breast Cancer | Malignant Neoplasm of Breast
NCT04419181

Withdrawn

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

HER2-positive Breast Cancer
NCT07140107

Enrolling by invitation

Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews

Non-Metastatic Breast Cancer
NCT06599216

Active, not recruiting

Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer

Breast Cancer | HR+/HER2- Breast Cancer
NCT02807597

Terminated

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

Breast Cancer | Cancer of the Breast
NCT04224272

Completed

A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer

HER2+/HR+ Breast Cancer
NCT06886659

Completed

A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)

Breast Cancer | Breast Neoplasms | Antineoplastic Agents | Breast Disease
NCT02685332

Active, not recruiting

Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA

Early Stage Breast Cancer
NCT04220203

Approved for marketing

Treatment Protocol of Tucatinib With Capecitabine and Trastuzumab in Patients With Unresectable Previously Treated HER2+ Breast Cancer

HER2-positive Breast Cancer
NCT05346224

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

Breast Cancer | Breast Neoplasms | HER2-positive Breast Cancer
NCT04789096

Terminated

Tucatinib Together With Pembrolizumab and Trastuzumab (TUGETHER)

Breast Cancer | HER2-positive Breast Cancer
NCT03568448

Active, not recruiting

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

HER2 Negative Breast Cancer
NCT04215146

Active, not recruiting

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Breast Cancer Metastatic
NCT04450706

Completed

Functional Precision Oncology for Metastatic Breast Cancer (FORESEE)

HER2-negative Breast Cancer
NCT05710666

Active, not recruiting

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

HER2-positive Breast Cancer
NCT06481553

Active, not recruiting

RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody

Breast Cancer Stage IV
NCT06470490

Completed

Effect of Psycho-Educational Program and Relaxation Training on Resilience Among Women With Breast Cancer

Women With Breast Cancer
NCT04245150

Active, not recruiting

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

Invasive Breast Cancer | DCIS
NCT01468883

Completed

The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

Breast Cancer
NCT05458401

Completed

EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan (EUROPA T-DXd)

HER2-positive Breast Cancer
NCT02278120

Completed

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (MONALEESA-7)

Advanced Metastatic Breast Cancer
NCT05371860

Withdrawn

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Breast Cancer | HER2-positive Breast Cancer
NCT06007118

Completed

Adjuvant Partial-breast Irradiation Using Stereotactic Body Radiation Therapy

Early-stage Breast Cancer
NCT00309478

Completed

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Early-stage Breast Cancer
NCT00625417

Completed

Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors

Breast Cancer
NCT04366713

Completed

A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib

HER2 Amplified Breast Cancer
NCT02698891

Completed

Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer

Early Stage Breast Cancer
NCT03619044

Terminated

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. (REVER)

HER2-positive Breast Cancer
NCT03511781

Completed

Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer (HYPORT)

Carcinoma Breast Stage IV
NCT04980989

Completed

Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software

Breast Cancer, Early-Onset
NCT04858282

Completed

Application-Enabled Shared Decision-Making

Breast Cancer | Mastectomy | Breast-Conserving Surgery
NCT01220076

Completed

Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ (TAM)

Non Metastatic Breast Cancer
NCT03946683

Completed

Cyberknife for Early Stage Breast Cancer

Early Stage Breast Cancer
NCT04697043

Unknown

The Benefit of Surgery in Stage IV of Breast Cancer

Breast Cancer Stage IV
NCT04607473

Unknown

ABUS for Early-stage Breast Cancer

Early Stage Breast Cancer
NCT02095210

Terminated

HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

HER2-positive Breast Cancer
NCT04498793

Unknown

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

HER2-negative Breast Cancer
NCT02485678

Completed

A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer (AToM)

Early Stage Breast Cancer
NCT02159157

Completed

A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer

Early Stage Breast Cancer
NCT04172350

Unknown

An Innovative Care-improvement Smartphone-based Perioperative Solution for Women Undergoing Breast Cancer Surgery (iCareBreast)

Surgery | Breast Cancer Female
NCT02947425

Unknown

TARGeted Intraoperative radioTherapy (TARGIT) Registry Database (TARGIT R)

Early-Stage Breast Carcinoma
NCT01390064

Completed

Vaccination of High Risk Breast Cancer Patients

Stage IV Breast Cancer
NCT01907529

Unknown

A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer (TENDENCY)

Stage III Breast Cancer
NCT03947242

Unknown

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.

HER2 Positive Breast Cancer
NCT03919253

Unknown

Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study

HER2-positive Breast Cancer
NCT02306265

Completed

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

Breast Cancer | Cancer Screening | Tumors, Breast
NCT03644329

Unknown

Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.

Postmenopause | Breast Cancer Survivors

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations